Skip to main content

Table 1 Hematological and iron overload parameters of patients with β-Thalassemia Major and their subgroups based on chelation treatment in the current and previous study6

From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes

Parameter (normal range) Current study Previous study
Iron Chelator DFX
n = 26
DFO+/−DFP
n = 10
Total
n = 36
DFO
n = 29
Length of current treatment (mean months) 60.4 ± 9.1 101.2 ± 66.1   
Hemoglobin (g/dl)
(12–15)
8.3 ± 0.95 8.12 ± 0.88 8.25 ± 0.9 8.9 ± 0.9
Serum ferritin (ng/ml)
(22–322)
2597 ± 1669** 4801 ± 1893** 3209 ± 1976 3839 ± 1780
Total amount of iron transfused for prior 10 years (mmol) 1100 ± 105 1388 ± 80 1180 ± 413 1218 ± 391
  1. Data expressed as mean ± SD
  2. *P < 0.05 between chelation-based subgroups of β-thalassemia patients
  3. **P < 0.05 between total patients in the current study and those in the previous study